photo of A/Prof Kirsten Perrett

A/Prof Kirsten Perrett

A/Prof Kirsten Perrett

Details

Role Group Leader/Clinician-Scientist Fellow
Research area Population health

Contact

Associate Professor Kirsten Perrett (MBBS (Hons), FRACP, PhD) is Co-Group Leader of the Population Allergy Research Group and Deputy Director of the Melbourne Children's Trials Centre, Murdoch Children's Research Institute; Paediatric Allergist and Vaccinologist in the Department's of Allergy and Immunology, Royal Children's Hospital; and Honorary Principal Fellow at The University of Melbourne, Australia.

Kirsten has had over 15 years of experience in leading Investigator-led and Industry-sponsored vaccine clinical trials and in vaccine safety research. Her PhD on persistence of immunity and immunological memory to meningococcal vaccines was done at the Oxford Vaccine Group (University of Oxford, UK) and NHMRC post-doctoral fellowship on maternal immunisation at the Vaccine and Immunisation Research Group (MCRI). Additionally, Kirsten spent a year as a Visiting Scholar with the Stanford Lucille-Packard Children’s Hospital Vaccine Program (Stanford University, US) in 2013-2014.

In 2018 Kirsten moved her research focus from testing strategies for prevention of infectious disease (through vaccination) to food allergy. Her current program of clinical trials research is focused on investigating novel strategies for the prevention and early intervention/treatment of food allergy, eczema and atopic disease. She is also involved in research investigating immunological mechanisms underlying allergic disease pathogenesis and exploring strategies to improve the diagnostic accuracy of minimally invasive tests for food allergy diagnosis. She has been awarded research grants on over $27.8 million in competitive, government, philanthropic and industry research funding and is a Chief Investigator of the NHMRC Centre for Food and Allergy Research. She is a Key Opinion Leader for the conduct of clinical trials in Allergy and Vaccinology.
Associate Professor Kirsten Perrett (MBBS (Hons), FRACP, PhD) is Co-Group Leader of the Population Allergy Research Group and Deputy Director of the Melbourne Children's Trials Centre, Murdoch Children's Research Institute; Paediatric Allergist and...
Associate Professor Kirsten Perrett (MBBS (Hons), FRACP, PhD) is Co-Group Leader of the Population Allergy Research Group and Deputy Director of the Melbourne Children's Trials Centre, Murdoch Children's Research Institute; Paediatric Allergist and Vaccinologist in the Department's of Allergy and Immunology, Royal Children's Hospital; and Honorary Principal Fellow at The University of Melbourne, Australia.

Kirsten has had over 15 years of experience in leading Investigator-led and Industry-sponsored vaccine clinical trials and in vaccine safety research. Her PhD on persistence of immunity and immunological memory to meningococcal vaccines was done at the Oxford Vaccine Group (University of Oxford, UK) and NHMRC post-doctoral fellowship on maternal immunisation at the Vaccine and Immunisation Research Group (MCRI). Additionally, Kirsten spent a year as a Visiting Scholar with the Stanford Lucille-Packard Children’s Hospital Vaccine Program (Stanford University, US) in 2013-2014.

In 2018 Kirsten moved her research focus from testing strategies for prevention of infectious disease (through vaccination) to food allergy. Her current program of clinical trials research is focused on investigating novel strategies for the prevention and early intervention/treatment of food allergy, eczema and atopic disease. She is also involved in research investigating immunological mechanisms underlying allergic disease pathogenesis and exploring strategies to improve the diagnostic accuracy of minimally invasive tests for food allergy diagnosis. She has been awarded research grants on over $27.8 million in competitive, government, philanthropic and industry research funding and is a Chief Investigator of the NHMRC Centre for Food and Allergy Research. She is a Key Opinion Leader for the conduct of clinical trials in Allergy and Vaccinology.

Top Publications

  • Soriano, VX, Peters, RL, Moreno-Betancur, M, Ponsonby, A-L, Gell, G, Odoi, A, Perrett, KP, Tang, MLK, Gurrin, LC, Allen, KJ, et al. Association Between Earlier Introduction of Peanut and Prevalence of Peanut Allergy in Infants in Australia. JAMA 328(1) : 48 -56 2022
    view publication
  • Palmer, DJ, Sullivan, TR, Campbell, DE, Nanan, R, Gold, MS, Hsu, PS, Netting, MJ, McWilliam, V, Koplin, JJ, Perrett, KP, et al. PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks’ gestation during pregnancy to 4 months’ lactation on infant IgE-mediated egg and peanut allergy outcomes. BMJ Open 12(6) : e056925 2022
    view publication
  • O’Connor, M, Moreno-Betancur, M, Goldfeld, S, Wake, M, Patton, G, Dwyer, T, Tang, MLK, Saffery, R, Craig, JM, Loke, J, et al. Data Resource Profile: Melbourne Children's LifeCourse initiative (LifeCourse).. International Journal of Epidemiology 2022
    view publication
  • Peters, RL, Guarnieri, I, Tang, MLK, Lowe, AJ, Dharmage, SC, Perrett, KP, Gurrin, LC, Koplin, JJ. The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study. Journal of Allergy and Clinical Immunology 2022
    view publication
  • Currell, A, Koplin, JJ, Lowe, AJ, Perrett, KP, Ponsonby, A-L, Tang, MLK, Dharmage, SC, Peters, RL. Mode of Birth Is Not Associated With Food Allergy Risk in Infants. The Journal of Allergy and Clinical Immunology In Practice 2022
    view publication

Page 1 of 22

Professional activities